ATE281172T1 - Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms - Google Patents

Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms

Info

Publication number: ATE281172T1
Authority: AT; Austria
Prior art keywords: choline; cdp; alcohol withdrawal; withdrawal syndrome; treat alcohol
Prior art date: 2000-03-29

Application number

AT01936147T

Other languages

English (en)

Inventor

Rafael Foguet

Jorge Ramentol

Rafael Lozano

Julian Agut

Jesus Torres

Manuel M Raga

Josep M Castell

Jose A Ortiz

Original Assignee

Ferrer Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-29

Filing date

2001-03-28

Publication date

2004-11-15

2001-03-28 Application filed by Ferrer Int filed Critical Ferrer Int

2004-11-15 Application granted granted Critical

2004-11-15 Publication of ATE281172T1 publication Critical patent/ATE281172T1/de

Links

206010053164 Alcohol withdrawal syndrome Diseases 0.000 title abstract 2
208000029650 alcohol withdrawal Diseases 0.000 title abstract 2
229960001231 choline Drugs 0.000 title 1
RZZPDXZPRHQOCG-OJAKKHQRSA-M CDP-choline(1-) Chemical compound O[C@@H]1[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OCC[N+](C)(C)C)O[C@H]1N1C(=O)N=C(N)C=C1 RZZPDXZPRHQOCG-OJAKKHQRSA-M 0.000 abstract 2
229940126601 medicinal product Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Addiction (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Medicinal Preparation (AREA)

AT01936147T 2000-03-29 2001-03-28 Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms ATE281172T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
ES200000765A ES2170649B1 (es)	2000-03-29	2000-03-29	Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
PCT/EP2001/003536 WO2001072288A2 (en)	2000-03-29	2001-03-28	Use of cdp-choline for the treatment of alcohol withdrawal syndrome

Publications (1)

Publication Number	Publication Date
ATE281172T1 true ATE281172T1 (de)	2004-11-15

Family

ID=8492914

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01936147T ATE281172T1 (de)	2000-03-29	2001-03-28	Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms

Country Status (21)

Country	Link
US (1)	US6894032B2 (de)
EP (1)	EP1267892B1 (de)
JP (1)	JP4724348B2 (de)
KR (1)	KR100794891B1 (de)
AT (1)	ATE281172T1 (de)
AU (2)	AU6214101A (de)
BR (1)	BR0109477A (de)
CA (1)	CA2402707C (de)
CZ (1)	CZ298933B6 (de)
DE (1)	DE60106890T2 (de)
DK (1)	DK1267892T3 (de)
ES (1)	ES2170649B1 (de)
IL (2)	IL151163A0 (de)
MX (1)	MXPA02009442A (de)
NO (1)	NO329766B1 (de)
NZ (1)	NZ520825A (de)
PL (1)	PL199291B1 (de)
PT (1)	PT1267892E (de)
RU (1)	RU2251422C2 (de)
WO (1)	WO2001072288A2 (de)
ZA (1)	ZA200206349B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001068104A1 (en)	2000-03-16	2001-09-20	The Mclean Hospital Corporation	Compounds for the treatment of psychiatric or substance abuse disorders
CA2492725A1 (en) *	2002-07-11	2004-01-22	Yamasa Corporation	Medicinal composition for drug-induced neuropathy
PT1565055E (pt)	2002-11-08	2013-09-16	Mclean Hospital Corp	Compostos para o tratamento da dependência e da privação de tabaco
WO2004058160A2 (en) *	2002-12-20	2004-07-15	The Mclean Hospital Corporation	Compounds for the normalization of the sleep/wake cycle
JP2007508315A (ja) *	2003-10-08	2007-04-05	ザマクレーンホスピタルコーポレーション	ω−３脂肪酸を含む組み合わせを用いて、精神障害、物質乱用障害、および他の障害を治療する方法
WO2005122767A1 (en)	2004-06-10	2005-12-29	Mclean Hospital Corporation	Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
US7947661B2 (en)	2004-08-11	2011-05-24	The Mclean Hospital Corporation	Compounds for the treatment of marihuana dependence, withdrawal, and usage

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5308627A (en) *	1990-08-07	1994-05-03	Umbdenstock Jr Anthony J	Nutritional supplement for optimizing cellular health
RU2072239C1 (ru) *	1991-01-11	1997-01-27	Институт биохимии СО РАМН	Способ коррекции метаболической зависимости от алкоголя и средство л.е.панина для его осуществления
DE4342173A1 (de) *	1993-12-10	1995-06-14	Lohmann Therapie Syst Lts	Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer
CN101066276A (zh) *	1994-07-01	2007-11-07	威尔斯塔特医疗公司	用于治疗全身性炎症和炎性肝炎的嘧啶核苷酸前体
RU2127589C1 (ru) *	1997-06-03	1999-03-20	Порембский Ярослав Олегович	Способ лечения стрессорных поражений нервной системы
KR100217488B1 (ko) *	1997-06-03	1999-09-01	맹섭	골프채의 헤드커버
US5958896A (en) *	1997-08-08	1999-09-28	The Mclean Hospital	Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure
WO2001068104A1 (en) *	2000-03-16	2001-09-20	The Mclean Hospital Corporation	Compounds for the treatment of psychiatric or substance abuse disorders

2000
- 2000-03-29 ES ES200000765A patent/ES2170649B1/es not_active Expired - Fee Related
2001
- 2001-03-28 AU AU6214101A patent/AU6214101A/xx active Pending
- 2001-03-28 DK DK01936147T patent/DK1267892T3/da active
- 2001-03-28 CZ CZ20023245A patent/CZ298933B6/cs not_active IP Right Cessation
- 2001-03-28 NZ NZ520825A patent/NZ520825A/en not_active IP Right Cessation
- 2001-03-28 EP EP01936147A patent/EP1267892B1/de not_active Expired - Lifetime
- 2001-03-28 MX MXPA02009442A patent/MXPA02009442A/es active IP Right Grant
- 2001-03-28 PT PT01936147T patent/PT1267892E/pt unknown
- 2001-03-28 PL PL363177A patent/PL199291B1/pl unknown
- 2001-03-28 AU AU2001262141A patent/AU2001262141B2/en not_active Ceased
- 2001-03-28 JP JP2001570249A patent/JP4724348B2/ja not_active Expired - Fee Related
- 2001-03-28 AT AT01936147T patent/ATE281172T1/de active
- 2001-03-28 KR KR1020027012966A patent/KR100794891B1/ko not_active Expired - Fee Related
- 2001-03-28 IL IL15116301A patent/IL151163A0/xx active IP Right Grant
- 2001-03-28 BR BR0109477-7A patent/BR0109477A/pt not_active Application Discontinuation
- 2001-03-28 DE DE60106890T patent/DE60106890T2/de not_active Expired - Lifetime
- 2001-03-28 RU RU2002129579/15A patent/RU2251422C2/ru not_active IP Right Cessation
- 2001-03-28 WO PCT/EP2001/003536 patent/WO2001072288A2/en not_active Ceased
- 2001-03-28 CA CA002402707A patent/CA2402707C/en not_active Expired - Fee Related
- 2001-03-28 US US10/240,159 patent/US6894032B2/en not_active Expired - Lifetime
2002
- 2002-08-08 ZA ZA200206349A patent/ZA200206349B/en unknown
- 2002-08-09 IL IL151163A patent/IL151163A/en not_active IP Right Cessation
- 2002-09-24 NO NO20024574A patent/NO329766B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR20030005248A (ko)	2003-01-17
NO20024574L (no)	2002-11-22
IL151163A0 (en)	2003-04-10
AU2001262141B2 (en)	2005-03-10
DK1267892T3 (da)	2005-03-07
AU6214101A (en)	2001-10-08
DE60106890T2 (de)	2005-11-03
MXPA02009442A (es)	2003-02-12
ES2170649B1 (es)	2003-06-16
RU2251422C2 (ru)	2005-05-10
BR0109477A (pt)	2003-06-03
NO20024574D0 (no)	2002-09-24
WO2001072288A2 (en)	2001-10-04
NO329766B1 (no)	2010-12-13
CZ20023245A3 (cs)	2003-03-12
EP1267892A2 (de)	2003-01-02
ZA200206349B (en)	2003-08-08
PL199291B1 (pl)	2008-09-30
ES2170649A1 (es)	2002-08-01
KR100794891B1 (ko)	2008-01-14
EP1267892B1 (de)	2004-11-03
NZ520825A (en)	2004-04-30
RU2002129579A (ru)	2004-03-27
DE60106890D1 (de)	2004-12-09
CA2402707A1 (en)	2001-10-04
PT1267892E (pt)	2005-03-31
IL151163A (en)	2011-01-31
PL363177A1 (en)	2004-11-15
US6894032B2 (en)	2005-05-17
JP2003528133A (ja)	2003-09-24
JP4724348B2 (ja)	2011-07-13
CZ298933B6 (cs)	2008-03-12
WO2001072288A3 (en)	2002-05-10
US20030162749A1 (en)	2003-08-28
CA2402707C (en)	2007-11-13

Similar Documents

Publication	Publication Date	Title
IL171977A (en)	2010-12-30	Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same
MY133732A (en)	2007-11-30	Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines
BR0112591A (pt)	2003-07-22	Derivados de acridina e sua aplicação como medicamento
BG104727A (en)	2001-05-31	Pharmaceutical composition of topiramate
DK1346041T3 (da)	2007-07-02	Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
BR0111913A (pt)	2004-01-06	Análogos de gabapentina para distúrbios do sono
DE59401401D1 (de)	1997-02-06	Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
PA8529501A1 (es)	2003-06-30	Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa -7."
GEP20053617B (en)	2005-09-26	Bridged Piperazine Derivatives
BR0112807A (pt)	2003-07-01	Derivados de indol e sua aplicação como medicamento
DE60026491D1 (de)	2006-05-04	Melagatran zur behandlung von entzündungen
ATE360428T1 (de)	2007-05-15	Analgetisches arzneimittel
DE60106890D1 (de)	2004-12-09	Verwendung von cdp-choline zur behandlung des alkoholentzugsyndroms
DE69917005D1 (de)	2004-06-09	Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
DE60123117D1 (de)	2006-10-26	Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
EE200200088A (et)	2003-04-15	Bis-sulfoonamiidide kasutamine ravimite valmistamiseks, mis on ette nähtud hüperlipideemia ärahoidmiseks või raviks
IT1307786B1 (it)	2001-11-19	Analoghi di ceramidi, processo per la loro preparazione e loro usocome antitumorali.
BG105984A (bg)	2002-04-30	Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
PE20030236A1 (es)	2003-04-10	Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
DE60306503D1 (de)	2006-08-10	Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
GEP20053512B (en)	2005-05-10	S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
HUP9801925A1 (hu)	2000-02-28	Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
BR0112690A (pt)	2003-06-24	Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos
CY1107037T1 (el)	2012-09-26	Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου
YU24603A (sh)	2006-05-25	Novi farmaceutski preparati koji sadrže epinastin i pseudoefedrin

Legal Events

Date

Code

Title

Description

2005-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1267892

Country of ref document: EP